Grepafloxacin, (S)-
| Code | Size | Price |
|---|
| TAR-T25461-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25461-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T25461-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Grepafloxacin, (S)- is an oral broad-spectrum fluoroquinolone antibacterial used for the treatment of bacterial infections.
CAS:
146761-69-5
Formula:
C19H22FN3O3
Molecular Weight:
359.401
Purity:
0.98
SMILES:
C[C@H]1CN(CCN1)c1cc2n(cc(C(O)=O)c(=O)c2c(C)c1F)C1CC1
References
1. Gontijo AV, Brillault J, Gr?goire N, Lamarche I, Gobin P, Couet W, Marchand S. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin. Antimicrob Agents Chemother. 2014 Jul;58(7):3942-9. doi: 10.1128/AAC.02818-14. Epub 2014 May 5. PubMed PMID: 24798283; PubMed Central PMCID: PMC4068515.
2. Ramos-Pay?n M, Villar-Navarro M, Fern?ndez-Torres R, Callej?n-Moch?n M, Bello-L?pez MA. Electromembrane extraction (EME)--an easy, novel and rapid extraction procedure for the HPLC determination of fluoroquinolones in wastewater samples. Anal Bioanal Chem. 2013 Mar;405(8):2575-84. doi: 10.1007/s00216-012-6664-5. Epub 2013 Jan 11. PubMed PMID: 23307130.
3. Hishigaki H, Kuhara S. hERGAPDbase: a database documenting hERG channel inhibitory potentials and APD-prolongation activities of chemical compounds. Database (Oxford). 2011 May 17;2011:bar017. doi: 10.1093/database/bar017. Print 2011. PubMed PMID: 21586548; PubMed Central PMCID: PMC3096323.
4. Green JR, Diaz GJ, Limberis JT, Houseman KA, Su Z, Martin RL, Cox BF, Kantor S, Gintant GA. Ventricular rate adaptation: a novel, rapid, cellular-based in-vitro assay to identify proarrhythmic and torsadogenic compounds. J Pharmacol Toxicol Methods. 2011 Jul-Aug;64(1):68-73. doi: 10.1016/j.vascn.2011.03.005. Epub 2011 Apr 2. PubMed PMID: 21440075.